New England Professional Planning Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315K Hold
1,250
0.12% 35
2026
Q1
$272K Sell
1,250
-22
-2% -$4.88K 0.11% 34
2025
Q4
$291K Buy
1,272
+22
+2% +$5.01K 0.12% 32
2025
Q3
$289K Hold
1,250
0.13% 31
2025
Q2
$232K Hold
1,250
0.11% 44
2025
Q1
$262K Hold
1,250
0.13% 38
2024
Q4
$222K Hold
1,250
0.11% 45
2024
Q3
$247K Hold
1,250
0.12% 39
2024
Q2
$214K Sell
1,250
-4
-0.3% -$663 0.11% 44
2024
Q1
$228K Buy
+1,254
New +$216K 0.12% 43

Other funds holding ABBV

New England Professional Planning Group's ABBV Position: Q2 2026 in Review

New England Professional Planning Group held its AbbVie (ABBV) position steady in Q2 2026 at 1,250 shares worth $315K. The position accounts for 0.12% of the portfolio, ranked #35.

New England Professional Planning Group first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • New England Professional Planning Group held 1,250 shares of AbbVie worth $315K as of Q2 2026.
  • New England Professional Planning Group left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.12% of New England Professional Planning Group's portfolio in Q2 2026, its #35 holding.
  • New England Professional Planning Group first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on New England Professional Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.